Drug-induced phospholipidosis.
D000818:Animals; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D001067:Appetite Depressants / Q000009:adverse effects*; D002745:Chlorphentermine / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology; D002850:Chromatography, Gel; D002855:Chromatography, Thin Layer; D003338:Corpus Luteum / Q000187:drug effects; D004347:Drug Interactions; D005260:Female; D002479:Inclusion Bodies / Q000032:analysis / Q000187:drug effects; D007985:Leydig Cells / Q000187:drug effects; D008064:Lipidoses / Q000097:blood / Q000139:chemically induced* / Q000473:pathology; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D008297:Male; D010743:Phospholipids / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D011619:Psychotropic Drugs / Q000009:adverse effects*; D011650:Pulmonary Alveoli / Q000648:ultrastructure; D013057:Spectrum Analysis
D000924:Anticholesteremic Agents; D001067:Appetite Depressants; D010743:Phospholipids; D011619:Psychotropic Drugs; D002745:Chlorphentermine